Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03682874 · ClinicalTrials.gov registry record
Identifying Novel Aging Targets for Treatment of Delirium
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 5
- Enrollment target
NCT03682874 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants.
The verdict
NCT03682874 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The long-term goal of this research program is to improve understanding of the mechanistic link between Alzheimer's disease (AD) neuropathology, acute delirium, and cognitive impairment following acute respiratory failure. In this pilot study, the study team will establish a prospective cohort of older patients with acute respiratory failure and obtain data on delirium duration, AD imaging and CSF biomarkers, and cognitive outcomes following critical illness.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2020-02-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03682874
The ClinicalTrials.gov registry entry for NCT03682874 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03682874 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03682874 about?
NCT03682874 is a clinical study titled "Identifying Novel Aging Targets for Treatment of Delirium". The long-term goal of this research program is to improve understanding of the mechanistic link between Alzheimer's disease (AD) neuropathology, acute delirium, and cognitive impairment following acute respiratory failure. In this pilot study, the study team will establish a prospective cohort of ol...
What is the current status of trial NCT03682874?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2018-10-10. Estimated completion is 2020-02-20.
Who is sponsoring clinical trial NCT03682874?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.